-
1
-
-
50149120366
-
Cellular mechanisms of tumour suppression by the retinoblastoma gene
-
18650841
-
Burkhart DL, Sage J. Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat Rev Cancer 2008; 8:671-82; PMID:18650841; http://dx.doi.org/10.1038/nrc2399
-
(2008)
Nat Rev Cancer
, vol.8
, pp. 671-682
-
-
Burkhart, D.L.1
Sage, J.2
-
2
-
-
50149084928
-
Tailoring to RB: Tumour suppressor status and therapeutic response
-
19143056
-
Knudsen ES, Knudsen KE. Tailoring to RB: tumour suppressor status and therapeutic response. Nat Rev Cancer 2008; 8:714-24; PMID:19143056; http://dx.doi.org/10.1038/nrc2401
-
(2008)
Nat Rev Cancer
, vol.8
, pp. 714-724
-
-
Knudsen, E.S.1
Knudsen, K.E.2
-
3
-
-
27644476029
-
Retinoblastoma protein acts as Pax 8 transcriptional coactivator
-
16007137
-
Miccadei S, Provenzano C, Mojzisek M, Natali PG, Civitareale D. Retinoblastoma protein acts as Pax 8 transcriptional coactivator. Oncogene 2005; 24:6993-7001; PMID:16007137; http://dx.doi.org/10.1038/sj.onc.1208861
-
(2005)
Oncogene
, vol.24
, pp. 6993-7001
-
-
Miccadei, S.1
Provenzano, C.2
Mojzisek, M.3
Natali, P.G.4
Civitareale, D.5
-
4
-
-
0034840594
-
The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation
-
11545733
-
Thomas DM, Carty SA, Piscopo DM, Lee JS, Wang WF, Forrester WC, Hinds PW. The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation. Mol Cell 2001; 8:303-16; PMID:11545733; http://dx.doi.org/10.1016/S1097-2765(01)00327-6
-
(2001)
Mol Cell
, vol.8
, pp. 303-316
-
-
Thomas, D.M.1
Carty, S.A.2
Piscopo, D.M.3
Lee, J.S.4
Wang, W.F.5
Forrester, W.C.6
Hinds, P.W.7
-
5
-
-
0030611964
-
PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors
-
9133423
-
Scott EW, Fisher RC, Olson MC, Kehrli EW, Simon MC, Singh H. PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors. Immunity 1997; 6:437-47; PMID:9133423; http://dx.doi.org/10.1016/S1074-7613(00)80287-3
-
(1997)
Immunity
, vol.6
, pp. 437-447
-
-
Scott, E.W.1
Fisher, R.C.2
Olson, M.C.3
Kehrli, E.W.4
Simon, M.C.5
Singh, H.6
-
6
-
-
84881236410
-
Positive feedback between PU.1 and the cell cycle controls myeloid differentiation
-
23868921
-
Kueh HY, Champhekar A, Nutt SL, Elowitz MB, Rothenberg EV. Positive feedback between PU.1 and the cell cycle controls myeloid differentiation. Science 2013; 341:670-3; PMID:23868921; http://dx.doi.org/10.1126/science.1240831
-
(2013)
Science
, vol.341
, pp. 670-673
-
-
Kueh, H.Y.1
Champhekar, A.2
Nutt, S.L.3
Elowitz, M.B.4
Rothenberg, E.V.5
-
7
-
-
67649981723
-
Direct binding of pRb/E2F-2 to GATA-1 regulates maturation and terminal cell division during erythropoiesis
-
19513100
-
Kadri Z, Shimizu R, Ohneda O, Maouche-Chretien L, Gisselbrecht S, Yamamoto M, Romeo PH, Leboulch P, Chretien S. Direct binding of pRb/E2F-2 to GATA-1 regulates maturation and terminal cell division during erythropoiesis. PLoS Biol 2009; 7:e1000123; PMID:19513100; http://dx.doi.org/10.1371/journal.pbio.1000123
-
(2009)
Plos Biol
, vol.7
-
-
Kadri, Z.1
Shimizu, R.2
Ohneda, O.3
Maouche-Chretien, L.4
Gisselbrecht, S.5
Yamamoto, M.6
Romeo, P.H.7
Leboulch, P.8
Chretien, S.9
-
8
-
-
0142027901
-
PU.1 and pRB interact and cooperate to repress GATA-1 and block erythroid differentiation
-
14559995
-
Rekhtman N, Choe KS, Matushansky I, Murray S, Stopka T, Skoultchi AI. PU.1 and pRB interact and cooperate to repress GATA-1 and block erythroid differentiation. Mol Cell Biol 2003; 23:7460-74; PMID:14559995; http://dx.doi.org/10.1128/MCB.23.21.7460-7474.2003
-
(2003)
Mol Cell Biol
, vol.23
, pp. 7460-7474
-
-
Rekhtman, N.1
Choe, K.S.2
Matushansky, I.3
Murray, S.4
Stopka, T.5
Skoultchi, A.I.6
-
9
-
-
0034760521
-
Ret-inoblastoma protein complexes with C/EBP proteins and activates C/EBP-mediated transcription
-
11596110
-
Charles A, Tang X, Crouch E, Brody JS, Xiao ZX. Ret-inoblastoma protein complexes with C/EBP proteins and activates C/EBP-mediated transcription. J Cell Biochem 2001; 83:414-25; PMID:11596110; http://dx.doi.org/10.1002/jcb.1239
-
(2001)
J Cell Biochem
, vol.83
, pp. 414-425
-
-
Charles, A.1
Tang, X.2
Crouch, E.3
Brody, J.S.4
Xiao, Z.X.5
-
10
-
-
0035957007
-
PRB induces Sp1 activity by relieving inhibition mediated by MDM2
-
11226218
-
Johnson-Pais T, Degnin C, Thayer MJ. pRB induces Sp1 activity by relieving inhibition mediated by MDM2. Proc Natl Acad Sci U S A 2001; 98:2211-6; PMID:11226218; http://dx.doi.org/10.1073/pnas.051415898
-
(2001)
Proc Natl Acad Sci U S A
, vol.98
, pp. 2211-2216
-
-
Johnson-Pais, T.1
Degnin, C.2
Thayer, M.J.3
-
11
-
-
0029886284
-
The retinoblastoma gene (Rb1) in acute myeloid leukaemia: Analysis of gene rearrangements, protein expression and comparison of disease outcome
-
8759895
-
Jamal R, Gale RE, Shaun N, Thomas B, Wheatley K, Linch DC. The retinoblastoma gene (rb1) in acute myeloid leukaemia: analysis of gene rearrangements, protein expression and comparison of disease outcome. Br J Haematol 1996; 94:342-51; PMID:8759895; http://dx.doi.org/10.1046/j.1365-2141.1996.d01-1804.x
-
(1996)
Br J Haematol
, vol.94
, pp. 342-351
-
-
Jamal, R.1
Gale, R.E.2
Shaun, N.3
Thomas, B.4
Wheatley, K.5
Linch, D.C.6
-
12
-
-
34250363611
-
Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment
-
17574022
-
Walkley CR, Shea JM, Sims NA, Purton LE, Orkin SH. Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment. Cell 2007; 129:1081-95; PMID:17574022; http://dx.doi.org/10.1016/j.cell.2007.03.055
-
(2007)
Cell
, vol.129
, pp. 1081-1095
-
-
Walkley, C.R.1
Shea, J.M.2
Sims, N.A.3
Purton, L.E.4
Orkin, S.H.5
-
13
-
-
52949114971
-
Hematopoietic stem cell quiescence is maintained by compound contributions of the reti-noblastoma gene family
-
18940733
-
Viatour P, Somervaille TC, Venkatasubrahmanyam S, Kogan S, McLaughlin ME, Weissman IL, Butte AJ, Passegue E, Sage J. Hematopoietic stem cell quiescence is maintained by compound contributions of the reti-noblastoma gene family. Cell Stem Cell 2008; 3:416-28; PMID:18940733; http://dx.doi.org/10.1016/j.stem.2008.07.009
-
(2008)
Cell Stem Cell
, vol.3
, pp. 416-428
-
-
Viatour, P.1
Somervaille, T.C.2
Venkatasubrahmanyam, S.3
Kogan, S.4
McLaughlin, M.E.5
Weissman, I.L.6
Butte, A.J.7
Passegue, E.8
Sage, J.9
-
14
-
-
84874647204
-
The genomic landscape of hypodiploid acute lymphoblastic leukemia
-
23334668
-
Holmfeldt L, Wei L, Diaz-Flores E, Walsh M, Zhang J, Ding L, Payne-Turner D, Churchman M, Andersson A, Chen SC, et al. The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat Genet 2013; 45:242-52; PMID:23334668; http://dx.doi.org/10.1038/ng.2532
-
(2013)
Nat Genet
, vol.45
, pp. 242-252
-
-
Holmfeldt, L.1
Wei, L.2
Diaz-Flores, E.3
Walsh, M.4
Zhang, J.5
Ding, L.6
Payne-Turner, D.7
Churchman, M.8
Ersson, A.9
Chen, S.C.10
-
15
-
-
0036852241
-
Cancer immunoediting: From immunosurveillance to tumor escape
-
12407406
-
Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 2002; 3:991-8; PMID:12407406; http://dx.doi.org/10.1038/ni1102-991
-
(2002)
Nat Immunol
, vol.3
, pp. 991-998
-
-
Dunn, G.P.1
Bruce, A.T.2
Ikeda, H.3
Old, L.J.4
Schreiber, R.D.5
-
16
-
-
84902959977
-
Myeloid-derived suppressor cell heterogeneity in human cancers
-
24965257
-
Solito S, Marigo I, Pinton L, Damuzzo V, Mandruz-zato S, Bronte V. Myeloid-derived suppressor cell heterogeneity in human cancers. Ann N Y Acad Sci 2014; 1319:47-65; PMID:24965257; http://dx.doi.org/10.1111/nyas.12469
-
(2014)
Ann N Y Acad Sci
, vol.1319
, pp. 47-65
-
-
Solito, S.1
Marigo, I.2
Pinton, L.3
Damuzzo, V.4
Mandruz-Zato, S.5
Bronte, V.6
-
17
-
-
84862127053
-
Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression
-
22313874
-
Ostrand-Rosenberg S, Sinha P, Beury DW, Clements VK. Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression. Semin Cancer Biol 2012; 22:275-81; PMID:22313874; http://dx.doi.org/10.1016/j.semcancer.2012.01.011
-
(2012)
Semin Cancer Biol
, vol.22
, pp. 275-281
-
-
Ostrand-Rosenberg, S.1
Sinha, P.2
Beury, D.W.3
Clements, V.K.4
-
19
-
-
85027923251
-
Epigenetic silencing of retino-blastoma gene regulates pathologic differentiation of myeloid cells in cancer
-
23354483
-
Youn JI, Kumar V, Collazo M, Nefedova Y, Cond-amine T, Cheng P, Villagra A, Antonia S, McCaffrey JC, Fishman M, et al. Epigenetic silencing of retino-blastoma gene regulates pathologic differentiation of myeloid cells in cancer. Nat Immunol 2013; 14:211-20; PMID:23354483; http://dx.doi.org/10.1038/ni.2526
-
(2013)
Nat Immunol
, vol.14
, pp. 211-220
-
-
Youn, J.I.1
Kumar, V.2
Collazo, M.3
Nefedova, Y.4
Cond-Amine, T.5
Cheng, P.6
Villagra, A.7
Antonia, S.8
McCaffrey, J.C.9
Fishman, M.10
-
20
-
-
34648840189
-
Loss of the retinoblastoma tumor suppressor: Differential action on transcriptional programs related to cell cycle control and immune function
-
17452985
-
Markey MP, Bergseid J, Bosco EE, Stengel K, Xu H, Mayhew CN, Schwemberger SJ, Braden WA, Jiang Y, Babcock GF, et al. Loss of the retinoblastoma tumor suppressor: differential action on transcriptional programs related to cell cycle control and immune function. Oncogene 2007; 26:6307-18; PMID:17452985; http://dx.doi.org/10.1038/sj.onc.1210450
-
(2007)
Oncogene
, vol.26
, pp. 6307-6318
-
-
Markey, M.P.1
Bergseid, J.2
Bosco, E.E.3
Stengel, K.4
Xu, H.5
Mayhew, C.N.6
Schwemberger, S.J.7
Braden, W.A.8
Jiang, Y.9
Babcock, G.F.10
-
21
-
-
84927768777
-
Retinoblastoma protein potentiates the innate immune response in hepatocytes: Significance to hepatocellular carcinoma
-
24824777
-
Hutcheson J, Bourgo RJ, Balaji U, Ertel A, Witkiewicz AK, Knudsen ES. Retinoblastoma protein potentiates the innate immune response in hepatocytes: significance to hepatocellular carcinoma. Hepatology 2014; PMID:24824777
-
(2014)
Hepatology
-
-
Hutcheson, J.1
Bourgo, R.J.2
Balaji, U.3
Ertel, A.4
Witkiewicz, A.K.5
Knudsen, E.S.6
-
22
-
-
84860577638
-
A shared role for RBF1 and dCAP-D3 in the regulation of transcription with consequences for innate immunity
-
22496667
-
Longworth MS, Walker JA, Anderssen E, Moon NS, Gladden A, Heck MM, Ramaswamy S, Dyson NJ. A shared role for RBF1 and dCAP-D3 in the regulation of transcription with consequences for innate immunity. PLoS Genet 2012; 8:e1002618; PMID:22496667; http://dx.doi.org/10.1371/journal.pgen.1002618
-
(2012)
Plos Genet
, vol.8
-
-
Longworth, M.S.1
Walker, J.A.2
Erssen, E.3
Moon, N.S.4
Gladden, A.5
Heck, M.M.6
Ramaswamy, S.7
Dyson, N.J.8
-
23
-
-
5044220448
-
The critical role of type-1 innate and acquired immunity in tumor immunother-apy
-
15471553
-
Ikeda H, Chamoto K, Tsuji T, Suzuki Y, Wakita D, Takeshima T, Nishimura T. The critical role of type-1 innate and acquired immunity in tumor immunother-apy. Cancer science 2004; 95:697-703; PMID:15471553; http://dx.doi.org/10.1111/j.1349-7006.2004.tb03248.x
-
(2004)
Cancer Science
, vol.95
, pp. 697-703
-
-
Ikeda, H.1
Chamoto, K.2
Tsuji, T.3
Suzuki, Y.4
Wakita, D.5
Takeshima, T.6
Nishimura, T.7
-
24
-
-
84864345639
-
New paradigms in type 2 immunity
-
22837519
-
Pulendran B, Artis D. New paradigms in type 2 immunity. Science 2012; 337:431-5; PMID:22837519; http://dx.doi.org/10.1126/science.1221064
-
(2012)
Science
, vol.337
, pp. 431-435
-
-
Pulendran, B.1
Artis, D.2
-
25
-
-
84905665420
-
Beneficial autoimmunity at body surfaces - immune surveillance and rapid type 2 immunity regulate tissue homeostasis and cancer
-
25101088
-
Dalessandri T, Strid J. Beneficial autoimmunity at body surfaces - immune surveillance and rapid type 2 immunity regulate tissue homeostasis and cancer. Front Immunol 2014; 5:347; PMID:25101088; http://dx.doi.org/10.3389/fimmu.2014.00347
-
(2014)
Front Immunol
, vol.5
, pp. 347
-
-
Dalessandri, T.1
Strid, J.2
-
26
-
-
0029837401
-
Interleukin-6 promotes multiple myeloma cell growth via phosphorylation of retinoblastoma protein
-
8822942
-
Urashima M, Ogata A, Chauhan D, Vidriales MB, Teoh G, Hoshi Y, Schlossman RL, DeCaprio JA, Anderson KC. Interleukin-6 promotes multiple myeloma cell growth via phosphorylation of retinoblastoma protein. Blood 1996; 88:2219-27; PMID:8822942
-
(1996)
Blood
, vol.88
, pp. 2219-2227
-
-
Urashima, M.1
Ogata, A.2
Chauhan, D.3
Vidriales, M.B.4
Teoh, G.5
Hoshi, Y.6
Schlossman, R.L.7
Decaprio, J.A.8
Erson, K.C.9
-
27
-
-
0025775929
-
Repression of the interleukin 6 gene promoter by p53 and the retinoblas-toma susceptibility gene product
-
1652755
-
Santhanam U, Ray A, Sehgal PB. Repression of the interleukin 6 gene promoter by p53 and the retinoblas-toma susceptibility gene product. Proc Natl Acad Sci U S A 1991; 88:7605-9; PMID:1652755; http://dx.doi.org/10.1073/pnas.88.17.7605
-
(1991)
Proc Natl Acad Sci U S A
, vol.88
, pp. 7605-7609
-
-
Santhanam, U.1
Ray, A.2
Sehgal, P.B.3
-
28
-
-
0028125327
-
Absence of retinoblastoma protein expression results in auto-crine production of interleukin-6 and promotes the autonomous growth of acute myeloid leukemia blast cells
-
7967742
-
Zhu YM, Bradbury DA, Keith FJ, Russell N. Absence of retinoblastoma protein expression results in auto-crine production of interleukin-6 and promotes the autonomous growth of acute myeloid leukemia blast cells. Leukemia 1994; 8:1982-8; PMID:7967742
-
(1994)
Leukemia
, vol.8
, pp. 1982-1988
-
-
Zhu, Y.M.1
Bradbury, D.A.2
Keith, F.J.3
Russell, N.4
-
29
-
-
0033517297
-
PRB is required for interferon-gamma-induction ofthe MHC class II abeta gene
-
10490828
-
Zhu X, Pattenden S, Bremner R. pRB is required for interferon-gamma-induction ofthe MHC class II abeta gene. Oncogene 1999; 18:4940-7; PMID:10490828; http://dx.doi.org/10.1038/sj.onc.1202876
-
(1999)
Oncogene
, vol.18
, pp. 4940-4947
-
-
Zhu, X.1
Pattenden, S.2
Bremner, R.3
-
30
-
-
0030954856
-
IFN gamma inducibility of class II transactivator is specifically lacking in human tumour lines: Relevance to reti-noblastoma protein rescue of IFN-gamma inducibility of the HLA class II genes
-
9315472
-
Lu Y, Tschickardt ME, Schmidt BJ, Blanck G. IFN gamma inducibility of class II transactivator is specifically lacking in human tumour lines: relevance to reti-noblastoma protein rescue of IFN-gamma inducibility of the HLA class II genes. Immunol Cell Biol 1997; 75:325-32; PMID:9315472; http://dx.doi.org/10.1038/icb.1997.50
-
(1997)
Immunol Cell Biol
, vol.75
, pp. 325-332
-
-
Lu, Y.1
Tschickardt, M.E.2
Schmidt, B.J.3
Blanck, G.4
-
31
-
-
0029930050
-
Apoptosis-independent retinoblastoma protein rescue of HLA class II messenger RNA IFN-gamma inducibility in non-small cell lung carcinoma cells. Lack of surface class II expression associated with a specific defect in HLA-DRA induction
-
8786310
-
Lu Y, Boss JM, Hu SX, Xu HJ, Blanck G. Apoptosis-independent retinoblastoma protein rescue of HLA class II messenger RNA IFN-gamma inducibility in non-small cell lung carcinoma cells. Lack of surface class II expression associated with a specific defect in HLA-DRA induction. J Immunol 1996; 156:2495-2502; PMID:8786310
-
(1996)
J Immunol
, vol.156
, pp. 2495-2502
-
-
Lu, Y.1
Boss, J.M.2
Hu, S.X.3
Xu, H.J.4
Blanck, G.5
-
32
-
-
0028073607
-
Retinoblastoma protein regulation ofsurface CD74 (Invariant chain) expression in breast carcinoma cells
-
7997248
-
Lu Y, Ussery GD, Jacim M, Tschickardt M, Boss JM, Blanck G. Retinoblastoma protein regulation ofsurface CD74 (invariant chain) expression in breast carcinoma cells. Mol Immunol 1994; 31:1365-8; PMID:7997248; http://dx.doi.org/10.1016/0161-5890(94)90055-8
-
(1994)
Mol Immunol
, vol.31
, pp. 1365-1368
-
-
Lu, Y.1
Ussery, G.D.2
Jacim, M.3
Tschickardt, M.4
Boss, J.M.5
Blanck, G.6
-
33
-
-
0028315885
-
Blanck G. Evidence for retinoblastoma protein (RB) dependent and independent IFN-gamma responses: RB coor-dinately rescues IFN-gamma induction of MHC class II gene transcription in noninducible breast carcinoma cells
-
8134104
-
Lu Y, Ussery GD, Muncaster MM, Gallie BL, Blanck G. Evidence for retinoblastoma protein (RB) dependent and independent IFN-gamma responses: RB coor-dinately rescues IFN-gamma induction of MHC class II gene transcription in noninducible breast carcinoma cells. Oncogene 1994; 9:1015-9; PMID:8134104
-
(1994)
Oncogene
, vol.9
, pp. 1015-1019
-
-
Lu, Y.1
Ussery, G.D.2
Muncaster, M.M.3
Gallie, B.L.4
-
34
-
-
0031574235
-
Retinoblastoma protein expression facilitates chromatin remodeling at the HLA-DRA promoter
-
9396821
-
Osborne A, Tschickardt M, Blanck G. Retinoblastoma protein expression facilitates chromatin remodeling at the HLA-DRA promoter. Nucleic Acids Res 1997; 25:5095-102; PMID:9396821; http://dx.doi.org/10.1093/nar/25.24.5095
-
(1997)
Nucleic Acids Res
, vol.25
, pp. 5095-5102
-
-
Osborne, A.1
Tschickardt, M.2
Blanck, G.3
-
35
-
-
28944445094
-
Oct-1 DNA binding activity unresponsive to retinoblastoma protein expression prevents MHC class II induction in a non-small cell lung carcinoma cell line
-
16360016
-
Osborne AR, Zhang H, Blanck G. Oct-1 DNA binding activity unresponsive to retinoblastoma protein expression prevents MHC class II induction in a non-small cell lung carcinoma cell line. Mol Immunol 2006; 43:710-6; PMID:16360016; http://dx.doi.org/10.1016/j.molimm.2005.03.013
-
(2006)
Mol Immunol
, vol.43
, pp. 710-716
-
-
Osborne, A.R.1
Zhang, H.2
Blanck, G.3
-
36
-
-
0034804390
-
Histone deacetylase activity represses gamma inter-feron-inducible HLA-DR gene expression following the establishment of a DNase I-hypersensitive chroma- tin conformation
-
11533238
-
Osborne A, Zhang H, Yang WM, Seto E, Blanck G. Histone deacetylase activity represses gamma inter-feron-inducible HLA-DR gene expression following the establishment of a DNase I-hypersensitive chroma- tin conformation. Mol Cell Biol 2001; 21:6495-506; PMID:11533238; http://dx.doi.org/10.1128/MCB.21.19.6495-6506.2001
-
(2001)
Mol Cell Biol
, vol.21
, pp. 6495-6506
-
-
Osborne, A.1
Zhang, H.2
Yang, W.M.3
Seto, E.4
Blanck, G.5
-
37
-
-
0032767139
-
Retinoblastoma protein expression leads to reduced Oct-1 DNA binding activity and enhances interleukin-8 expression
-
10437913
-
Zhang H, Shepherd AT, Eason DD, Wei S, Diaz JI, Djeu JY, Wu GD, Blanck G. Retinoblastoma protein expression leads to reduced Oct-1 DNA binding activity and enhances interleukin-8 expression. Cell Growth Differ1999; 10:457-65; PMID:10437913
-
Cell Growth Differ1999
, vol.10
, pp. 457-465
-
-
Zhang, H.1
Shepherd, A.T.2
Eason, D.D.3
Wei, S.4
Diaz, J.I.5
Djeu, J.Y.6
Wu, G.D.7
Blanck, G.8
-
38
-
-
3142691424
-
Oct-1 maintains an intermediate, stable state ofHLA-DRA promoter repression in Rb-defective cells: An Oct-1-containing repressosome that prevents NF-Y binding to the HLA-DRA promoter
-
15105429
-
Osborne AR, Zhang H, Fejer G, Palubin KM, Niesen MI, Blanck G. Oct-1 maintains an intermediate, stable state ofHLA-DRA promoter repression in Rb-defective cells: an Oct-1-containing repressosome that prevents NF-Y binding to the HLA-DRA promoter. J Biol Chem 2004; 279:28911-9; PMID:15105429; http://dx.doi.org/10.1074/jbc.M403118200
-
(2004)
J Biol Chem
, vol.279
, pp. 28911-28919
-
-
Osborne, A.R.1
Zhang, H.2
Fejer, G.3
Palubin, K.M.4
Niesen, M.I.5
Blanck, G.6
-
39
-
-
84870358839
-
Regulation of interlocking gene regulatory network subcircuits by a small molecule inhibitor of retinoblastoma protein (RB) phosphorylation: Cancer cell expression of HLA-DR
-
23041127
-
Pillai S, Szekeres K, Lawrence NJ, Chellappan SP, Blanck G. Regulation of interlocking gene regulatory network subcircuits by a small molecule inhibitor of retinoblastoma protein (RB) phosphorylation: cancer cell expression of HLA-DR. Gene 2013; 512:403-7; PMID:23041127; http://dx.doi.org/10.1016/j.gene.2012.09.092
-
(2013)
Gene
, vol.512
, pp. 403-407
-
-
Pillai, S.1
Szekeres, K.2
Lawrence, N.J.3
Chellappan, S.P.4
Blanck, G.5
-
40
-
-
58249119590
-
Linkage of a tumor immune function and cell cycle de-regulation via a gene regulatory network subcircuit
-
18952290
-
Xu L, Niesen MI, Blanck G. Linkage of a tumor immune function and cell cycle de-regulation via a gene regulatory network subcircuit. Mol Immunol 2009; 46:569-75; PMID:18952290; http://dx.doi.org/10.1016/j.molimm.2008.07.035
-
(2009)
Mol Immunol
, vol.46
, pp. 569-575
-
-
Xu, L.1
Niesen, M.I.2
Blanck, G.3
-
41
-
-
0025129211
-
The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV-16 differ in reti-noblastoma protein binding and other properties
-
2153238
-
Gage JR, Meyers C, Wettstein FO. The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV-16 differ in reti-noblastoma protein binding and other properties. J Virol 1990; 64:723-30; PMID:2153238
-
(1990)
J Virol
, vol.64
, pp. 723-730
-
-
Gage, J.R.1
Meyers, C.2
Wettstein, F.O.3
-
42
-
-
0032753789
-
Cell transformation by the E7 oncoprotein of human papillomavirus type 16: Interactions with nuclear and cytoplasmic target proteins
-
10547667
-
Zwerschke W, Jansen-Durr P. Cell transformation by the E7 oncoprotein of human papillomavirus type 16: interactions with nuclear and cytoplasmic target proteins. Adv Cancer Res 2000; 78:1-29; PMID:10547667; http://dx.doi.org/10.1016/S0065-230X(08)61022-2
-
(2000)
Adv Cancer Res
, vol.78
, pp. 1-29
-
-
Zwerschke, W.1
Jansen-Durr, P.2
-
43
-
-
0038813683
-
Brain tumors and polyoma-viruses
-
12707848
-
Croul S, Otte J, Khalili K. Brain tumors and polyoma-viruses. J Neurovirol 2003; 9:173-82; PMID:12707848; http://dx.doi.org/10.1080/13550280390194055
-
(2003)
J Neurovirol
, vol.9
, pp. 173-182
-
-
Croul, S.1
Otte, J.2
Khalili, K.3
-
44
-
-
0037330709
-
Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins
-
12584163
-
Helt AM, Galloway DA. Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins. Carcinogenesis 2003; 24:159-69; PMID:12584163; http://dx.doi.org/10.1093/carcin/24.2.159
-
(2003)
Carcinogenesis
, vol.24
, pp. 159-169
-
-
Helt, A.M.1
Galloway, D.A.2
-
45
-
-
84894166118
-
The changing landscape of hepatocellular carcinoma: Etiology, genetics, and therapy
-
24388934
-
Knudsen ES, Gopal P, Singal AG. The changing landscape of hepatocellular carcinoma: etiology, genetics, and therapy. Am J Pathol 2014; 184:574-83; PMID:24388934; http://dx.doi.org/10.1016/j.ajpath.2013.10.028
-
(2014)
Am J Pathol
, vol.184
, pp. 574-583
-
-
Knudsen, E.S.1
Gopal, P.2
Singal, A.G.3
-
46
-
-
3142724031
-
Toll-like receptor signalling
-
15229469
-
Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4:499-511; PMID:15229469; http://dx.doi.org/10.1038/nri1391
-
(2004)
Nat Rev Immunol
, vol.4
, pp. 499-511
-
-
Akira, S.1
Takeda, K.2
-
47
-
-
57849159061
-
Toll-like receptors and cancer
-
19052556
-
Rakoff-Nahoum S, Medzhitov R. Toll-like receptors and cancer. Nat Rev Cancer 2009; 9:57-63; PMID:19052556; http://dx.doi.org/10.1038/nrc2541
-
(2009)
Nat Rev Cancer
, vol.9
, pp. 57-63
-
-
Rakoff-Nahoum, S.1
Medzhitov, R.2
-
48
-
-
84861313228
-
Rb/E2F1 regulates the innate immune receptor Toll-like receptor 3 in epithelial cells
-
22310660
-
Taura M, Suico MA, Koyama K, Komatsu K, Miyakita R, Matsumoto C, Kudo E, Kariya R, Goto H, Kitajima S, et al. Rb/E2F1 regulates the innate immune receptor Toll-like receptor 3 in epithelial cells. Mol Cell Biol 2012; 32:1581-90; PMID:22310660; http://dx.doi.org/10.1128/MCB.06454-11
-
(2012)
Mol Cell Biol
, vol.32
, pp. 1581-1590
-
-
Taura, M.1
Suico, M.A.2
Koyama, K.3
Komatsu, K.4
Miyakita, R.5
Matsumoto, C.6
Kudo, E.7
Kariya, R.8
Goto, H.9
Kitajima, S.10
-
49
-
-
68149097084
-
Activation of NF-kB pathway by virus infection requires Rb expression
-
19649275
-
Garcia MA, Gallego P, Campagna M, Gonzalez-Santa-maria J, Martinez G, Marcos-Villar L, Vidal A, Esteban M, Rivas C. Activation of NF-kB pathway by virus infection requires Rb expression. PLoS One 2009; 4: e6422; PMID:19649275; http://dx.doi.org/10.1371/journal.pone.0006422
-
(2009)
Plos One
, vol.4
-
-
Garcia, M.A.1
Gallego, P.2
Campagna, M.3
Gonzalez-Santa-Maria, J.4
Martinez, G.5
Marcos-Villar, L.6
Vidal, A.7
Esteban, M.8
Rivas, C.9
-
50
-
-
0023731010
-
SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene
-
2839300
-
DeCaprio JA, Ludlow JW, Figge J, Shew JY, Huang CM, Lee WH, Marsilio E, Paucha E, Livingston DM. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 1988; 54:275-83; PMID:2839300; http://dx.doi.org/10.1016/0092-8674(88)90559-4
-
(1988)
Cell
, vol.54
, pp. 275-283
-
-
Decaprio, J.A.1
Ludlow, J.W.2
Figge, J.3
Shew, J.Y.4
Huang, C.M.5
Lee, W.H.6
Marsilio, E.7
Paucha, E.8
Livingston, D.M.9
-
51
-
-
0029871773
-
BK virus large T antigen: Interactions with the retinoblastoma family of tumor suppressor proteins and effects on cellular growth control
-
8642665
-
Harris KF, Christensen JB, Imperiale MJ. BK virus large T antigen: interactions with the retinoblastoma family of tumor suppressor proteins and effects on cellular growth control. J Virol 1996; 70:2378-86; PMID:8642665
-
(1996)
J Virol
, vol.70
, pp. 2378-2386
-
-
Harris, K.F.1
Christensen, J.B.2
Imperiale, M.J.3
-
52
-
-
0030931636
-
Role of cell cycle regulators in tumor formation in transgenic mice expressing the human neurotropic virus, JCV, early protein
-
9328827
-
Krynska B, Gordon J, Otte J, Franks R, Knobler R, DeLuca A, Giordano A, Khalili K. Role of cell cycle regulators in tumor formation in transgenic mice expressing the human neurotropic virus, JCV, early protein. J Cell Biochem 1997; 67:223-30; PMID:9328827; http://dx.doi.org/10.1002/(SICI)1097-4644(19971101)67:2%3c223::AID-JCB7%3e3.0.CO;2-Z
-
(1997)
J Cell Biochem
, vol.67
, pp. 223-230
-
-
Krynska, B.1
Gordon, J.2
Otte, J.3
Franks, R.4
Knobler, R.5
Deluca, A.6
Giordano, A.7
Khalili, K.8
-
53
-
-
84887152971
-
The T antigen locus of Merkel cell polyomavirus downregulates human Toll-like receptor 9 expression
-
24067965
-
Shahzad N, Shuda M, Gheit T, Kwun HJ, Cornet I, Saidj D, Zannetti C, Hasan U, Chang Y, Moore PS, et al. The T antigen locus of Merkel cell polyomavirus downregulates human Toll-like receptor 9 expression. J Virol 2013; 87:13009-19; PMID:24067965; http://dx.doi.org/10.1128/JVI.01786-13
-
(2013)
J Virol
, vol.87
, pp. 13009-13019
-
-
Shahzad, N.1
Shuda, M.2
Gheit, T.3
Kwun, H.J.4
Cornet, I.5
Saidj, D.6
Zannetti, C.7
Hasan, U.8
Chang, Y.9
Moore, P.S.10
-
54
-
-
0032477720
-
The polyoma virus T antigen interferes with interferon-inducible gene expression
-
9448289
-
Weihua X, Ramanujam S, Lindner DJ, Kudaravalli RD, Freund R, Kalvakolanu DV. The polyoma virus T antigen interferes with interferon-inducible gene expression. Proc Natl Acad Sci U S A 1998; 95:108-590; PMID:9448289; http://dx.doi.org/10.1073/pnas.95.3.1085
-
(1998)
Proc Natl Acad Sci U S A
, vol.95
, pp. 108-590
-
-
Weihua, X.1
Ramanujam, S.2
Lindner, D.J.3
Kudaravalli, R.D.4
Freund, R.5
Kalvakolanu, D.V.6
-
55
-
-
0034232047
-
Interferon alpha/beta-mediated inhibition and promotion of interferon gamma: STAT1 resolves a paradox
-
10881178
-
Nguyen KB, Cousens LP, Doughty LA, Pien GC, Durbin JE, Biron CA. Interferon alpha/beta-mediated inhibition and promotion of interferon gamma: STAT1 resolves a paradox. Nat Immunol 2000; 1:70-6; PMID:10881178; http://dx.doi.org/10.1038/76940
-
(2000)
Nat Immunol
, vol.1
, pp. 70-76
-
-
Nguyen, K.B.1
Cousens, L.P.2
Doughty, L.A.3
Pien, G.C.4
Durbin, J.E.5
Biron, C.A.6
-
56
-
-
84964036804
-
The emerging role of CXCL10 in cancer (Review)
-
22848232
-
Liu M, Guo S, Stiles JK. The emerging role of CXCL10 in cancer (Review). Oncol Lett 2011; 2:5839; PMID:22848232
-
(2011)
Oncol Lett
, vol.2
, pp. 5839
-
-
Liu, M.1
Guo, S.2
Stiles, J.K.3
-
57
-
-
35549003579
-
Regulation of interferon-gamma during innate and adaptive immune responses
-
17981204
-
Schoenborn JR, Wilson CB. Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol 2007; 96:41-101; PMID:17981204; http://dx.doi.org/10.1016/S0065-2776(07)96002-2
-
(2007)
Adv Immunol
, vol.96
, pp. 41-101
-
-
Schoenborn, J.R.1
Wilson, C.B.2
-
58
-
-
0034629279
-
Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis
-
10702232
-
Park JS, Kim EJ, Kwon HJ, Hwang ES, Namkoong SE, Um SJ. Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis. J Biol Chem 2000; 275:6764-9; PMID:10702232; http://dx.doi.org/10.1074/jbc.275.10.6764
-
(2000)
J Biol Chem
, vol.275
, pp. 6764-6769
-
-
Park, J.S.1
Kim, E.J.2
Kwon, H.J.3
Hwang, E.S.4
Namkoong, S.E.5
Um, S.J.6
-
59
-
-
84885611423
-
Human papillomavirus 16-encoded E7 protein inhibits IFN-gamma-mediated MHC class I antigen presentation and CTL-induced lysis by blocking IRF-1 expression in mouse keratino-cytes
-
23956301
-
Zhou F, Chen J, Zhao KN. Human papillomavirus 16-encoded E7 protein inhibits IFN-gamma-mediated MHC class I antigen presentation and CTL-induced lysis by blocking IRF-1 expression in mouse keratino-cytes. J General Virol 2013; 94:2504-14; PMID:23956301; http://dx.doi.org/10.1099/vir.0.054486-0
-
(2013)
J General Virol
, vol.94
, pp. 2504-2514
-
-
Zhou, F.1
Chen, J.2
Zhao, K.N.3
-
60
-
-
0037162471
-
Role of the E1A Rb-binding domain in repression of the NF-kappa B-dependent defense against tumor necrosis factor-alpha
-
12119420
-
Cook JL, Walker TA, Worthen GS, Radke JR. Role of the E1A Rb-binding domain in repression of the NF-kappa B-dependent defense against tumor necrosis factor-alpha. Proc Natl Acad Sci U S A 2002; 99:996-671; PMID:12119420; http://dx.doi.org/10.1073/pnas.162082999
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, pp. 671-996
-
-
Cook, J.L.1
Walker, T.A.2
Worthen, G.S.3
Radke, J.R.4
-
61
-
-
84870201146
-
Different regions othe HPV-E7 and Ad-E1A viral oncoproteins bind competitively but through distinct mechanisms to the CH1 trans activation domain of p300
-
23121466
-
Fera D, Marmorstein R. Different regions othe HPV-E7 and Ad-E1A viral oncoproteins bind competitively but through distinct mechanisms to the CH1 trans activation domain of p300. Biochemistry 2012; 51:952-434; PMID:23121466; http://dx.doi.org/10.1021/bi3011863
-
(2012)
Biochemistry
, vol.51
, pp. 434-952
-
-
Fera, D.1
Marmorstein, R.2
-
62
-
-
76749104377
-
Targeting the RB-pathway in cancer therapy
-
20145169
-
Knudsen ES, Wang JY. Targeting the RB-pathway in cancer therapy. Clin Cancer Res 2010; 16:1094-9; PMID:20145169; http://dx.doi.org/10.1158/1078-0432.CCR-09-0787
-
(2010)
Clin Cancer Res
, vol.16
, pp. 1094-1099
-
-
Knudsen, E.S.1
Wang, J.Y.2
-
63
-
-
84890555975
-
Current cervical cancer prevention strategies including cervical screening and prophylactic human papillomavirus vaccination: A review
-
24248011
-
Elfstrom KM, Herweijer E, Sundstrom K, Arnheim-Dahlstrom L. Current cervical cancer prevention strategies including cervical screening and prophylactic human papillomavirus vaccination: a review. Curr Opin Oncol 2014; 26:120-9; PMID:24248011; http://dx.doi.org/10.1097/CCO.0000000000000034
-
(2014)
Curr Opin Oncol
, vol.26
, pp. 120-129
-
-
Elfstrom, K.M.1
Herweijer, E.2
Sundstrom, K.3
Arnheim-Dahlstrom, L.4
-
64
-
-
84902097427
-
DNA vaccine encoding HPV-16 E7 with mutation in L-Y-C-Y-E pRb-binding motif induces potent anti-tumor responsesin mice
-
24880067
-
Bahrami AA, Ghaemi A, Tabarraei A, Sajadian A, Gorji A, Soleimanjahi H. DNA vaccine encoding HPV-16 E7 with mutation in L-Y-C-Y-E pRb-binding motif induces potent anti-tumor responsesin mice. J Virol Methods 2014; 206:12-8; PMID:24880067; http://dx.doi.org/10.1016/j.jviromet.2014.05.013
-
(2014)
J Virol Methods
, vol.206
, pp. 12-18
-
-
Bahrami, A.A.1
Ghaemi, A.2
Tabarraei, A.3
Sajadian, A.4
Gorji, A.5
Soleimanjahi, H.6
-
65
-
-
33947209498
-
Predictive value of p53 and pRb expression in superficial bladder cancer patients treated with BCG and interferon-alpha
-
17311305
-
Esuvaranathan K, Chiong E, Thamboo TP, Chan YH, Kamaraj R, Mahendran R, Teh M. Predictive value of p53 and pRb expression in superficial bladder cancer patients treated with BCG and interferon-alpha. Cancer 2007; 109:1097-105; PMID:17311305; http://dx.doi.org/10.1002/cncr.22503
-
(2007)
Cancer
, vol.109
, pp. 1097-1105
-
-
Esuvaranathan, K.1
Chiong, E.2
Thamboo, T.P.3
Chan, Y.H.4
Kamaraj, R.5
Mahendran, R.6
Teh, M.7
-
66
-
-
77951572370
-
Retinoblastoma protein expression predicts response to bacillus Calmette-Guerin immunotherapy in patients with T1G3 bladder cancer
-
18976938
-
Cormio L, Tolve I, Annese P, Saracino A, Zamparese R, Sanguedolce F, Bufo P, Battaglia M, Selvaggi FP, Carrieri G. Retinoblastoma protein expression predicts response to bacillus Calmette-Guerin immunotherapy in patients with T1G3 bladder cancer. Urol Oncol 2010; 28:285-9; PMID:18976938; http://dx.doi.org/10.1016/j.urolonc.2008.08.003
-
(2010)
Urol Oncol
, vol.28
, pp. 285-289
-
-
Cormio, L.1
Tolve, I.2
Annese, P.3
Saracino, A.4
Zamparese, R.5
Sanguedolce, F.6
Bufo, P.7
Battaglia, M.8
Selvaggi, F.P.9
Carrieri, G.10
-
67
-
-
84893965118
-
Immune modulation in cancer with antibodies
-
24188664
-
Page DB, Postow MA, Callahan MK, Allison JP, Wol-chok JD. Immune modulation in cancer with antibodies. Annu Rev Med 2014; 65:185-202; PMID:24188664; http://dx.doi.org/10.1146/annurev-med-092012-112807
-
(2014)
Annu Rev Med
, vol.65
, pp. 185-202
-
-
Page, D.B.1
Postow, M.A.2
Callahan, M.K.3
Allison, J.P.4
Wol-Chok, J.D.5
-
68
-
-
84858766182
-
The blockade of immune checkpoints in cancer immunotherapy
-
22437870
-
Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 2012; 12:25264; PMID:22437870; http://dx.doi.org/10.1038/nrc3239
-
(2012)
Nat Rev Cancer
, vol.12
, pp. 25264
-
-
Pardoll, D.M.1
-
69
-
-
1642344452
-
Activation of tumor-specific CD4(C) T lymphocytes by major his to compatibility complex class II tumor cell vaccines: A novel cell-based immunotherapy
-
14996751
-
Dissanayake SK, Thompson JA, Bosch JJ, Clements VK, Chen PW, Ksander BR, Ostrand-Rosenberg S. Activation of tumor-specific CD4(C) T lymphocytes by major his to compatibility complex class II tumor cell vaccines: a novel cell-based immunotherapy. Cancer Res 2004; 64:1867-74; PMID:14996751; http://dx.doi.org/10.1158/0008-5472.CAN-03-2634
-
(2004)
Cancer Res
, vol.64
, pp. 1867-1874
-
-
Dissanayake, S.K.1
Thompson, J.A.2
Bosch, J.J.3
Clements, V.K.4
Chen, P.W.5
Ksander, B.R.6
Ostrand-Rosenberg, S.7
-
70
-
-
34249323028
-
MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(C) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells
-
17483366
-
Bosch JJ, Thompson JA, Srivastava MK, Iheagwara UK, Murray TG, Lotem M, Ksander BR, Ostrand-Rosenberg S. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(C) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells. Cancer Res 2007; 67:4499-506; PMID:17483366; http://dx.doi.org/10.1158/0008-5472.CAN-06-3770
-
(2007)
Cancer Res
, vol.67
, pp. 4499-4506
-
-
Bosch, J.J.1
Thompson, J.A.2
Srivastava, M.K.3
Iheagwara, U.K.4
Murray, T.G.5
Lotem, M.6
Ksander, B.R.7
Ostrand-Rosenberg, S.8
-
71
-
-
37349020263
-
The absence of invariant chain in MHC II cancer vaccines enhances the activation of tumor-reactive type 1 CD4+ T lymphocytes
-
17724589
-
Thompson JA, Srivastava MK, Bosch JJ, Clements VK, Ksander BR, Ostrand-Rosenberg S. The absence of invariant chain in MHC II cancer vaccines enhances the activation of tumor-reactive type 1 CD4+ T lymphocytes. Cancer Immunol 2008; 57:389-98; PMID:17724589; http://dx.doi.org/10.1007/s00262-007-0381-5
-
(2008)
Cancer Immunol
, vol.57
, pp. 389-398
-
-
Thompson, J.A.1
Srivastava, M.K.2
Bosch, J.J.3
Clements, V.K.4
Ksander, B.R.5
Ostrand-Rosenberg, S.6
-
72
-
-
78049494663
-
MHC II lung cancer vaccines prime and boost tumor-specific CD4+ T cells that cross-react with multiple histologic subtypes of non-small cell lung cancer cells
-
20473949
-
Srivastava MK, Bosch JJ, Wilson AL, Edelman MJ, Ostrand-Rosenberg S. MHC II lung cancer vaccines prime and boost tumor-specific CD4+ T cells that cross-react with multiple histologic subtypes of non-small cell lung cancer cells. Int J Cancer 2010; 127:2612-21; PMID:20473949; http://dx.doi.org/10.1002/ijc.25462
-
(2010)
Int J Cancer
, vol.127
, pp. 2612-2621
-
-
Srivastava, M.K.1
Bosch, J.J.2
Wilson, A.L.3
Edelman, M.J.4
Ostrand-Rosenberg, S.5
|